Transforming the Understanding and Treatment of Neurodegeneration

Redefining the treatment of neurological disorders

At ImmunoBrain Checkpoint, we pioneer a transformative approach for treating neurological disorders, one that leverages the body’s own defense mechanisms: harnessing the power of the peripheral immune system in mitigating brain pathology.

Alzheimer’s disease clinical trial

We are currently investigating our lead program IBC-Ab002, a novel anti-PD-L1 antibody, in patients with early Alzheimer’s disease.

Targeting the peripheral immune system to benefit the brain

ImmunoBrain is building upon its unique understanding of how the peripheral immune system communicates with the brain.

What’s new?

To read more about our latest events.